supp.fit

Vitamin C, Vitamin E and Zinc: study protocols

53 study groups took Vitamin C together with Vitamin E and Zinc. These are the doses the studies gave. They are not a recommendation.

Vitamin C: what the research found →

Dose per serving from research: Vitamin C

53 study groups in 44 studies say how much Vitamin C participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 45% of 53 study groups.

Daily doseStudy groups
50 mg or less
3
50 mg to 100 mg
5
100 mg to 250 mg
24
250 mg to 500 mg
18
500 mg to 1 g
2
over 1 g
1

Dose per serving from research: Vitamin E

34 study groups in 32 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 41% of 34 study groups.

Daily doseStudy groups
5 mg or less
2
5 mg to 10 mg
4
10 mg to 25 mg
4
25 mg to 50 mg
14
50 mg to 100 mg
3
100 mg to 250 mg
2
250 mg to 500 mg
3
over 500 mg
2

Dose per serving from research: Zinc

53 study groups in 44 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 45% of 53 study groups.

Daily doseStudy groups
5 mg or less
2
5 mg to 10 mg
3
10 mg to 25 mg
24
25 mg to 50 mg
10
50 mg to 100 mg
12
over 100 mg
2

Commonly used together

51 of 53 study groups took Vitamin C, Vitamin E and Zinc with something else. Shown: what 3 or more different studies gave. The 10 most common of 14.

What was given together, not what works together.

Taken withStudy groups
Beta-Carotene
30
Selenium
24
Copper
15
Magnesium
6
Vitamin A
6
Vitamin B6
6
Vitamin B12
5
Folic Acid
4
Iron
4
Riboflavin
4

53 study groups

Study
Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial
2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India
40.2 mg7.5 mg7.8 mg1 year316
Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial
2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up
180 mg30 mg30 mg5 years164
Megadose vitamins in bladder cancer: a double-blind clinical trial
1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy
2 g—90 mg—35
"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants
1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition
120 mg30 mg20 mg8 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
500 mg400 IU80 mg8 years—
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
50 mg8 mg20 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
100 mg10 mg30 mg——
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility
500 mg400 IU80 mg339 weeks—
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population
120 mg30 mg20 mg2739 days—
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
120 mg30 mg20 mg2739 days—
[The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health]
2006 · antioxidant supplementation · Middle-aged adults in the general population
120 mg30 mg20 mg2738 days—
Antioxidant supplementation increases the risk of skin cancers in women but not in men
2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial
120 mg30 mg20 mg2738 days—
Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study
2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years
120 mg30 mg20 mg2738 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
500 mg400 IU80 mg339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
500 mg400 IU80 mg9 years—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline
120 mg15 mg20 mg2 years—
Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial
2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD)
500 mg400 mg25 mg17 weeks26
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MV · Patients with type 2 diabetes
200 mg100 mg20 mg120 days—
Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial
2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering
40.2 mg7.5 mg7.8 mg1 year316
A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study
2019 · verum group · Women aged 35–73 with healthy skin
80 mg2.3 mg3 mg12 weeks36
A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement
2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease
80 mg2.3 mg3 mg12 weeks30
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year
2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years
180 mg30 mg22.5 mg1 year15
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
200 mg100 mg20 mg120 days—
French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study
120 mg30 mg20 mg2922 days—
The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes
2004 · group MV · People with type 2 diabetes; age and sex not reported
200 mg150 mg30 mg90 days17
Combination oral antioxidant supplementation reduces blood pressure
1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints.
500 mg600 mg200 mg8 weeks—
The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes
2004 · group MV · Adults with type 2 diabetes; age and sex not reported
200 mg150 mg30 mg90 days17
Trace element supplementation in hemodialysis patients: a randomized controlled trial
2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease
100 mg250 IU50 mg180 days52
Trace element supplementation in hemodialysis patients: a randomized controlled trial
2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease
100 mg250 IU25 mg180 days47
High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy
2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery
500 mg400 IU50 mg60 days26
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men
226 mg—34.8 mg1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men
452 mg—69.6 mg1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men
452 mg400 mg69.6 mg1 day15
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin
2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy
600 mg300 mg150 mg48 weeks11
Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study
2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population
120 mg30 mg20 mg2 years—
Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation
2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation
120 mg30 mg20 mg3 weeks—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
120 mg15 mg20 mg26 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common
120 mg15 mg20 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
120 mg15 mg20 mg1 year—
Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects
1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years
120 mg30 mg20 mg26 weeks—
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
135 mg45 mg7.5 mg12 weeks30
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
270 mg90 mg15 mg6 weeks30
Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes
2005 · group MV · Patients with type 2 diabetes; age range and sex not specified
200 mg100 IU30 mg90 days17
Oxidative stress in humans during work at moderate altitude
1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported
500 mg—30 mg4 weeks15
Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training
1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m
500 mg400 IU30 mg2 weeks—
Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study
2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
120 mg30 mg20 mg2738 days—
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration
500 mg400 IU80 mg2433 days—
Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial
2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified
1 g800 mg60 mg120 days—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration
500 mg400 IU80 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
500 mg400 IU80 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
500 mg400 IU80 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
500 mg400 IU25 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
500 mg400 IU25 mg5 years—